{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:12:53Z","timestamp":1792026773837,"version":"4.4.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>In patients with locally advanced extraperitoneal rectal cancer, a multidisciplinary approach represents the standard treatment. However, considering the favorable prognosis in patients with major or complete response, radical surgery might represent overtreatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>This study aimed to evaluate postoperative short-term morbidity, functional outcome, and oncologic long-term outcome in patients with rectal cancer treated with local excision by transanal endoscopic microsurgery or radical surgery and to determine who achieved a complete or major pathological response (ypT0-1) after neoadjuvant treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>This was a retrospective study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>The study was conducted at a single center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients who had received neoadjuvant treatment by local excision with a major or complete pathological response at histological examination (transanal endoscopic microsurgery group) were compared to patients treated by radical surgery with the same pathological response (total mesorectal excision group).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>The interventions included local excision by transanal endoscopic microsurgery and radical surgery with total mesorectal excision.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOME MEASURES:<\/jats:title>\n            <jats:p>Postoperative short-term morbidity, functional outcome 1 year after surgery, and oncologic long-term outcome were measured.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Ninety-three patients were included in the study (35 in the transanal endoscopic microsurgery group and 58 in the mesorectal excision group). In the total mesorectal excision group, a sphincter-saving approach was possible in 89.7% (vs 100%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.049); a protective temporary stoma was necessary in 74.1% of radical procedures (vs 0%; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001), and 13.8% of these became permanent. Short-term postoperative morbidity was lower after local excision (14.3% vs 46.6%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.002). One year after surgery, the transanal endoscopic microsurgery group recorded better evacuation and continence function than the total mesorectal excision group. Oncologic outcome was similar between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITATIONS:<\/jats:title>\n            <jats:p>This study had a retrospective design.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>If a major or complete pathological response occurs after neoadjuvant treatment, an organ-sparing approach by local excision seems to offer the same oncologic results as radical surgery, but it has a better postoperative morbidity rate and better functional results. See <jats:bold>Video Abstract<\/jats:bold> at http:\/\/links.lww.com\/DCR\/B901.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>Microcirug\u00eda endosc\u00f3pica transanal versus escisi\u00f3n total del mesorrecto en c\u00e1ncer de recto ypT0-1 despu\u00e9s de radioquimioterapia preoperatoria: morbilidad posoperatoria, resultados funcionales y resultado oncol\u00f3gico a largo plazo<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>ANTECEDENTES:<\/jats:title>\n            <jats:p>En pacientes con c\u00e1ncer rectal extraperitoneal localmente avanzado, un abordaje multidisciplinario con radioquimioterapia preoperatoria y cirug\u00eda con escisi\u00f3n total del mesorrecto representa el tratamiento est\u00e1ndar. En pacientes que obtienen una respuesta mayor o completa, la cirug\u00eda radical puede representar un sobretratamiento, considerando el pron\u00f3stico favorable de estos casos.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJETIVO:<\/jats:title>\n            <jats:p>Evaluar la morbilidad posoperatoria a corto plazo, el resultado funcional y el resultado oncol\u00f3gico a largo plazo en pacientes con c\u00e1ncer de recto tratados con escisi\u00f3n local mediante microcirug\u00eda endosc\u00f3pica transanal o mediante cirug\u00eda radical y que obtuvieron una respuesta patol\u00f3gica completa o mayor (ypT0-1) despu\u00e9s del tratamiento neoadyuvante.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DISE\u00d1O:<\/jats:title>\n            <jats:p>Este fue un estudio retrospectivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>AJUSTE:<\/jats:title>\n            <jats:p>El estudio se realiz\u00f3 en un solo centro.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>ESCENARIO:<\/jats:title>\n            <jats:p>El estudio se realiz\u00f3 en un solo centro.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PACIENTES:<\/jats:title>\n            <jats:p>Se compar\u00f3 a los pacientes tratados, tras tratamiento neoadyuvante (1996\u20132016), mediante escisi\u00f3n local con respuesta patol\u00f3gica mayor o completa al examen histol\u00f3gico (grupo de microcirug\u00eda endosc\u00f3pica transanal), con los pacientes tratados mediante cirug\u00eda radical con la misma respuesta patol\u00f3gica (grupo de escisi\u00f3n mesorrectal total).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENCIONES:<\/jats:title>\n            <jats:p>Extirpaci\u00f3n local mediante microcirug\u00eda endosc\u00f3pica transanal y cirug\u00eda radical con escisi\u00f3n mesorrectal total.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PRINCIPALES MEDIDAS DE RESULTADO:<\/jats:title>\n            <jats:p>Morbilidad posoperatoria a corto plazo, resultado funcional a un a\u00f1o despu\u00e9s de la cirug\u00eda (evaluado con una puntuaci\u00f3n de evacuaci\u00f3n y continencia) y resultado oncol\u00f3gico a largo plazo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTADOS:<\/jats:title>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LIMITACIONES:<\/jats:title>\n            <jats:p>Las limitaciones de este estudio incluyen su dise\u00f1o retrospectivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSI\u00d3N:<\/jats:title>\n            <jats:p>Si se produce una respuesta patol\u00f3gica mayor o completa despu\u00e9s del tratamiento neoadyuvante, un abordaje con preservaci\u00f3n de \u00f3rganos mediante escisi\u00f3n local parece ofrecer los mismos resultados oncol\u00f3gicos que la cirug\u00eda radical, pero tiene una menor tasa de morbilidad postoperatoria y mejores resultados funcionales un a\u00f1o despu\u00e9s de la cirug\u00eda. Consulte <jats:bold>Video Resumen<\/jats:bold> en http:\/\/links.lww.com\/DCR\/B901. <jats:italic toggle=\"yes\">(Traducci\u00f3n\u2014Dr. Felipe Bellolio<\/jats:italic>)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dcr.0000000000002255","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T09:10:01Z","timestamp":1643015401000},"page":"1306-1315","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome"],"prefix":"10.1097","volume":"65","author":[{"given":"Gianluca","family":"Rizzo","sequence":"first","affiliation":[{"name":"U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato P.","family":"Pafundi","sequence":"additional","affiliation":[{"name":"U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sionne","sequence":"additional","affiliation":[{"name":"U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pietricola","sequence":"additional","affiliation":[{"name":"U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gambacorta","sequence":"additional","affiliation":[{"name":"U.O.C. Radioterapia Oncologica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[{"name":"U.O.C. Radioterapia Oncologica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Coco","sequence":"additional","affiliation":[{"name":"U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017.","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer.","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-20250505","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00384-007-0276-0","article-title":"Functional results after radiochemotherapy and total mesorectal excision for rectal cancer.","volume":"22","author":"Coco","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"issue":"suppl 3","key":"R8-20250505","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1463-1318.2006.01066.x","article-title":"Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy.","volume":"8","author":"Habr-Gama","year":"2006","journal-title":"Colorectal Dis"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10434-001-0801-2","article-title":"Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival.","volume":"8","author":"Onaitis","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1072-7515(01)01159-0","article-title":"Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients.","volume":"194","author":"Hiotis","year":"2002","journal-title":"J Am Coll Surg"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10350-004-0673-1","article-title":"Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy?","volume":"47","author":"Zmora","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/DCR.0b013e3182a2303e","article-title":"Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial.","volume":"56","author":"Pucciarelli","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.9809","article-title":"Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).","volume":"102","author":"Verseveld","year":"2015","journal-title":"Br J Surg"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ejso.2017.05.011","article-title":"Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer.","volume":"43","author":"Rizzo","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1007\/s00464-013-2842-6","article-title":"Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome.","volume":"27","author":"Coco","year":"2013","journal-title":"Surg Endosc"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1463-1318.2006.01186.x","article-title":"Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer.","volume":"9","author":"Doornebosch","year":"2007","journal-title":"Colorectal Dis"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ejso.2009.05.001","article-title":"Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention.","volume":"35","author":"De Graaf","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10350-005-0291-6","article-title":"Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer.","volume":"49","author":"Coco","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"R19-20250505","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijrobp.2004.01.051","article-title":"Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: phase I and II studies.","volume":"60","author":"Gambacorta","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20250505","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1245\/s10434-007-9396-6","article-title":"Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.","volume":"14","author":"Hospers","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R21-20250505","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/annonc\/mdj031","article-title":"A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer.","volume":"17","author":"Glynne-Jones","year":"2006","journal-title":"Ann Oncol"},{"key":"R22-20250505","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0360-3016(01)01618-2","article-title":"Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.","volume":"51","author":"Valentini","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20250505","first-page":"677","article-title":"A system for a transanal endoscopic rectum operation.","volume":"55","author":"Buess","year":"1984","journal-title":"Chirurg"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"R26-20250505","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery\u2013the clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br J Surg"},{"key":"R27-20250505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R28-20250505","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/BF02234388","article-title":"Colonic J-pouch function in rectal cancer patients: impact of adjuvant chemoradiotherapy.","volume":"44","author":"Gervaz","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"R29-20250505","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","article-title":"Etiology and management of fecal incontinence.","volume":"36","author":"Jorge","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"R30-20250505","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1200\/JCO.2002.20.3.817","article-title":"Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial.","volume":"20","author":"Marijnen","year":"2002","journal-title":"J Clin Oncol"},{"key":"R31-20250505","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1245\/s10434-013-3198-9","article-title":"Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials.","volume":"20","author":"Rahbari","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R32-20250505","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00384-007-0408-6","article-title":"Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?","volume":"23","author":"Horisberger","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"R33-20250505","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients: a Dutch colorectal cancer group study.","volume":"23","author":"Peeters","year":"2005","journal-title":"J Clin Oncol"},{"key":"R34-20250505","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"R35-20250505","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/SLA.0b013e3182759f1c","article-title":"Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.","volume":"256","author":"Smith","year":"2012","journal-title":"Ann Surg"},{"key":"R36-20250505","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/DCR.0b013e3182a84eba","article-title":"Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.","volume":"57","author":"Smith","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"R37-20250505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.2021.39.3_suppl.12","article-title":"Does non-TME surgery of rectal cancer compromise the chance of cure? Preliminary surgical salvage data from OPERA phase III randomized trial.","volume":"39","author":"Myint","year":"2021","journal-title":"J Clin Oncol"},{"key":"R38-20250505","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"R39-20250505","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/DCR.0000000000000293","article-title":"Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis.","volume":"58","author":"Kidane","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"R40-20250505","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10151-020-02394-4","article-title":"Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms.","volume":"25","author":"Rizzo","year":"2021","journal-title":"Tech Coloproctol"},{"key":"R41-20250505","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamasurg.2018.3752","article-title":"Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study.","volume":"154","author":"Stijns","year":"2019","journal-title":"JAMA Surg"},{"key":"R42-20250505","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00384-017-2942-1","article-title":"Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2-T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME).","volume":"33","author":"Serra-Aracil","year":"2018","journal-title":"Int J Colorectal Dis"}],"container-title":["Diseases of the Colon &amp; Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T23:09:23Z","timestamp":1746486563000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0000000000002255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0000000000002255","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}